Zyentia
Cambridge
About Zyentia
Zyentia is a biotech company, focuses on protein folding, conformation, and aggregation at a molecular level. Zyentia Ltd is a leading expert in understanding the molecular determinants underlying protein misfolding, aggregation and deposition in the tissue. We apply our proprietary technologies and expertise to the development of innovative therapies for a variety of protein misfolding disorders such as Type 2 Diabetes, Alzheimer’s disease and Parkinson disease. Mortgage calculator Zyentia is actively seeking parties interested in licensing and progressing its drug discovery programmes,
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.8M
- Last round: Series Unknown (Jun 2004)
- Website: zyentia.com
- Phone: 44 1223 496 787
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/zyentia-2155958 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.